Awareness, Care & Treatment in Obesity Management (ACTION) Study (ACTION)

July 17, 2019 updated by: Novo Nordisk A/S
The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

3767

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Honeoye Falls, New York, United States, 14472
        • Novo Nordisk Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Description

Inclusion Criteria:

  • GENERAL POPULATION
  • Agrees to AE reporting
  • Age at least 18 years
  • Lives in the US
  • Current BMI at least 30 kg/sqm
  • HEALTH CARE PROFESSIONALS
  • Agrees to AE reporting
  • Physician and board certified or NP/PA
  • Facility located in the U.S. and not Vermont
  • Spends at least 70% of time in direct patient care
  • Seen at least 100 patients in past month
  • Seen at least 10 patients in past month needing weight management
  • In practice 2-35 years
  • Not competitively employed
  • Primary Care Providers
  • Specialty is FP, IM, GP
  • Less than 50% patients seen for obesity
  • Obesity Specialists
  • Obesity medicine or weight loss specialist or at least 50% of patients seen for obesity
  • In practice 2-35 years
  • EMPLOYERS
  • Age at least 18 years
  • Works in the US
  • Director, Administrator, CHRO, VP or other title
  • Responsible for making or influencing decisions about health insurance or health and wellness programs
  • Company employs 500 or more full-time employees
  • Believes there is a weight issue at their company
  • Not competitively employed

Exclusion Criteria:

- None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
People with Obesity
General population, respondents are recruited via email and/or phone through an online panel company with which respondents have provided permission to be contacted for research
Other: No treatment given
Completion of a questionnaire
Healthcare Providers
Health care professionals, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes or through the AMA Masterfile
Other: No treatment given
Completion of a questionnaire
Employer representatives
Employers, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes
Other: No treatment given
Completion of a questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Awareness with the care and management of obesity among people with obesity
Time Frame: Start of interviews day 1 until day 15
Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Start of interviews day 1 until day 15
Awareness with the care and management of obesity among health care providers
Time Frame: Start of interviews day 1 until day 15
Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Start of interviews day 1 until day 15
Awareness with the care and management of obesity among employer representatives
Time Frame: Start of interviews day 1 until day 15
Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Start of interviews day 1 until day 15

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Novo Nordisk A/S

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 29, 2015

Primary Completion (Actual)

November 12, 2015

Study Completion (Actual)

November 12, 2015

Study Registration Dates

First Submitted

July 18, 2017

First Submitted That Met QC Criteria

July 18, 2017

First Posted (Actual)

July 21, 2017

Study Record Updates

Last Update Posted (Actual)

July 19, 2019

Last Update Submitted That Met QC Criteria

July 17, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • INS-4409
  • U1111-1198-9657 (Other Identifier: World Health Organization (WHO))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

According to the Novo Nordisk disclosure commitment on novonordisk-trials.com

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on No treatment given

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe